Welcome to Institute of Genomics
Genoscope Home Page
The CNRGH is the French national research center which enables a response to scientific questions necessitating high throughput sequencing and genotyping thanks to the development and deployment of innovative integrated technologies. The organization of the CNRGH enables optimization of genetic and genomic research on human diseases by creating indispensable links between cohort constitution (DNA samples), identification of the responsible genes, and study of the transcriptome and epigenome.
List of the main projects of the Institut de Génomique
THE CNRGH LABORATORIES
Team leader: Jörg TostE-mail: jorg.tostcng.fr
The Epigenetic and Environment Laboratory (LEE) aims at obtaining a complete picture of the epigenetic changes in various contexts pertinent to human health.
The Laboratory team has set up a robust process, unique in France, for the identification and validation in human diseases of the epigenetic modifications of which DNA methylation, miRNA and chromatin conformation changes. The LEE masters a variety of bisulfite genome sequencing technologies for analysis of DNA methylation and hydroxymethylation and works in close cooperation with the CNRGH high- and intermediate-throughput platforms. The technologies may be adapted to the various quantities of material at the outset down to less than 50 ng of isolated DNA. The associated bioinformatics pipelines also available at the LEE for processing the data and identifying the methylated regions undergo continuous refinement. Another technology currently used in numerous projects is the Illumina BeadChip 450K for which a dedicated bioinformatics pipeline has been developed. The DNA methylation changes thus identified are subsequently validated using the pyrosequencing technology developed by the Laboratory. RNAs are analyzed by small RNA‑seq or using a panel of qPCR tests based on LNA. The modifications of the miRNA and methylation of DNA are compared with the changes in the histones and other DNA binding proteins by ChIP-seq. while the regulatory components are identified using the innovative ATAC-seq. test based on transposase. While the team initially focused on the epigenetic changes in cancer, the team's objective has evolved over the last 3 years with a focus on analysis of epigenetic changes in complex human diseases including autoimmune diseases, inflammatory diseases and allergic diseases together with neurodegenerative diseases. A second focus is on the epigenome changes caused by environmental factors such as viruses (e.g. HIV), bacteria or low-dose radiation exposure.
The technologies available for whole-genome analysis are as follows: whole genome bisulfite sequencing, MeDIP-seq, smallRNA-seq, ChIP-seq, ATAC-seq, Illumina BeadChip 450K
The technologies available for analysis of specific loci: pyrosequencing (methylation, mutations), E-ice-COLD-PCR (mutations), qPCR (miRNA)
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.